http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1142927-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9433d383d1922b3df0ca6c182c7d3925 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D253-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 1981-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1983-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efd1b345a97381c585bed66371df101d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e084eb6707ec2a4fdd102a725aa357f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_689b4cef6e1f2a273e900b16e12ab7ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2c9f61af2035a4fbbc499588ce31a4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a79f888714a4d72d3c3eb8ff0f3a444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2564f3d81aae3a09920e4d1e162a6cfc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be83e1fa8bea51bf51e12e30554ca219 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_658057f7363c2700910378284b34af33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e4b9254ee2ca3bc686df40f5993967c |
| publicationDate | 1983-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1142927-A |
| titleOfInvention | Condensed as-triazine derivatives and process for preparing the same |
| abstract | ABSTRACT The invention relates to new condensed as-triazine derivatives of the general formula /I/ /I/ wherein Z represents a buta-1,3 dienyl group or a group of the formula /a/, /b/, /c/ or /d/ /a/ /b/ /c/ /d/ R1 denotes a C1-10 alkyl group, an oxo group or a C6-10 aryl or C6-10 aryl-/C1-3 alkyl/ group optionally substituted by one or more identical or different substituents selected from the group consisting of amino, nitro, C1-? alkyl, C1-6 alkoxy, hydroxy and halogen, R2 stands for hydrogen, C1-10 alkyl or amino, R3 represents hydrogen, C1-10 alkyl or C6-10 aryl or C6-10 aryl-/C1-3 alkyl/ optionally substituted by one or more identical or different substituents selected from the group consisting of nitro, amino, C1-6 alkyl, C1-6 alkoxy, hydroxy and halogen, X- denotes an anion, and n is O or 1, with the proviso that if n is 0, R1 is other than an oxo group and R1 and R2 form together a double bond, and with the further provisos that if n is 1, R1 represents an oxo group and the symbols R? and R? are not present, and if Z is a buta-1,3-dienyl group and R1 denotes an oxo group, R3 is other than unsubstituted phenyl. The new compounds of the general formula /I/ can be prepared by cyclizing the compounds of the general formula /II/ or /V/, wherein R1, Z, R3 and R7 have the above defined meanings, R4 is a leaving group and R7 represents hydrogen or C1-10 alkyl. The new compounds of the general formula /I/ possess a valuable antidepressant effect and can advantageously be used in the therapy. |
| priorityDate | 1980-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 115.